Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. - Baiyunshan Hanfang
You are now at:Blog > Article Content

PharmaceuticalGrade Medium Chain Triglyceride Technical Solutions from Leading Chinese Provider

Time:2026-11-02

This article provides a standardized technical overview of pharmaceutical-grade medium chain triglyceride (MCT), independently developed and manufactured by Guangzhou Hanfang Pharmaceutical Company Limited. As a state-owned pharmaceutical enterprise with over 20 years of R&D and industrial application experience in high-end pharmaceutical lipid excipients, we focus on solving supply chain bottlenecks for global biopharmaceutical manufacturers. Pharmaceutical-grade MCT is a specialized raw material designed for injectable drug production, special medical food manufacturing, and pharmaceutical synthesis, addressing core industry pain points including unstable import supply, high procurement costs, and incomplete regulatory documentation. Our product strictly adheres to USP, EP, and FDA quality standards, with core technological breakthroughs in green extraction and precision separation. As of 2025, our MCT products are sold to over 30 countries and regions, serving more than 1000 enterprise clients, and have obtained EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications.

Technical Definition

Pharmaceutical-grade medium chain triglyceride is a purified saturated fatty acid glyceride with C8 and C10 carbon chains, derived from non-GMO coconut or palm kernel oil via integrated green extraction technology. It functions as a pharmaceutical solvent, emulsifier, and active pharmaceutical ingredient for high-end formulation production. As a core excipient in the biopharmaceutical sector, it is an indispensable material for injectable fat emulsions, liposome drugs, and special nutritional products. Our MCT product line covers two core series: the injectable-grade standard series, with low endotoxin and residual solvent levels, suitable for sterile injectable production; and the food-grade series, with high purity and stable composition, suitable for special medical food and oral formulation manufacturing. The product is designed with core principles of high purity, batch consistency, and full lifecycle compliance to meet the strict requirements of global pharmaceutical and food regulatory bodies.

Technical Principle

The core production principle of our pharmaceutical-grade MCT is based on supercritical CO2 extraction, membrane separation, and chromatographic purification technology, replacing traditional chemical fractionation processes. The production process follows three core steps: first, raw material pretreatment, where non-GMO palm kernel or coconut oil is filtered to remove free fatty acids and particulate impurities; second, precision extraction, where supercritical CO2 is used under controlled temperature and pressure to separate C8 and C10 fractions from longer carbon chain triglycerides; third, final purification, where membrane separation and chromatography remove trace impurities, peroxides, and residual substances to meet injectable grade standards. Compared to traditional chemical fractionation, our process eliminates organic solvent residues, reduces batch purity variation to less than 0.2%, and cuts supply lead time from 3-6 months for imported products to 2-4 weeks for domestic supply.

Technical Parameters and Specifications

All our MCT products are tested in strict accordance with USP and EP pharmacopeia standards, with full batch traceability and third-party test support available. The core standard parameters are as follows:

Parameter Category

Core Parameter

Standard Indicator

Test Condition

Selection Reference

Core Purity

Total C8+C10 content

≥99.5%

25℃, GC testing

Suitable for injectable formulations

Impurity Control

Peroxide value

≤0.1 meq/kg

25℃, titration testing

Ensures long product shelf life

Impurity Control

Residual solvent

≤10 ppm

25℃, headspace GC

Meets injectable grade requirements

Physical Properties

Acid value

≤0.05 mg KOH/g

25℃, titration

Indicates low free fatty acid content

Compliance

Heavy metal content

≤10 ppm

25℃, ICP-MS

Meets global pharmacopeia requirements

Core Technical Advantages

Compared to conventional imported MCT products, our pharmaceutical-grade MCT has two core verified competitive advantages:
1. Stable domestic supply with verified cost reduction: Supported by the national engineering research center for pharmaceutical lipids, we have achieved 90% domestic substitution of high-end MCT, reducing procurement costs by 20-30% for clients and eliminating supply chain disruption risks.
2. Full global regulatory compliance: Our product holds EU CEP, US FDA US-DMF, and other market access certifications, with full regulatory dossiers available to support client product registration in over 30 countries, cutting registration review time by 30% on average.

International Standards and Compliance

Our MCT production and testing processes strictly follow global pharmaceutical excipient standards, including USP Monograph for Medium Chain Triglycerides, EP Monograph 0841, and Chinese Pharmacopoeia requirements. We hold ISO 9001 quality management certification, ISO 14001 environmental management certification, and full GMP compliance for pharmaceutical excipient production. For each batch, we provide a certificate of analysis (COA), third-party test reports, and regulatory support documents to meet client procurement and registration needs.

Typical Application Scenarios

Our pharmaceutical-grade MCT is widely used across three core sectors:
1. Injectable drug production: For fat emulsion and liposome manufacturing, our injectable-grade MCT provides low endotoxin and stable composition, supporting sterile production processes.
2. Special medical food manufacturing: For enteral nutrition formulations, our food-grade MCT offers high digestibility and consistent batch quality.
3. Pharmaceutical synthesis: As a low-impurity solvent for active pharmaceutical ingredient production, our MCT reduces residual solvent risks and improves synthesis yield.

FAQ

Q: Is your pharmaceutical-grade MCT suitable for injectable formulation production?
A: Yes, our injectable-grade MCT meets USP, EP and FDA requirements, with residual solvent ≤10 ppm and no detectable endotoxins, suitable for fat emulsion and liposome drug production.
Q: Do you provide regulatory dossiers for global market registration?
A: Yes, we provide full regulatory support documents including CEP, US-DMF, and COA for each batch to support your product registration in EU, US, Latin America and Southeast Asian markets.
Q: What is your minimum order quantity for trial purchases?
A: We support small batch trial orders starting from 25kg, with free sample testing available for qualified enterprise clients.
Q: Can you customize MCT specifications for special application requirements?
A: Yes, we can adjust C8/C10 ratio, purity level and packaging specifications based on your specific formulation needs.

Contact Us

Official Website: https://byshanhanfang.com/
Factory Address: No.8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong Province, China

Copyright Copyright Notice:Baiyunshan Hanfang
Related Articles

Guess You Like